Medicure Inc. MPH.V
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX-V · Canada · medicure.com
Medicure Inc. is a Canadian pharmaceutical company focused on the development and commercialization of cardiovascular therapeutics, primarily in the U.S. market. The company markets AGGRASTAT® (tirofiban hydrochloride) injection and ZYPITAMAG® (pitavastatin) tablets through its U.S. subsidiary, Medicure Pharma Inc. It also operates Marley Drug, an online pharmacy serving patients across all 50 U.S. states.
Key ratios
FreeCashFlowOnSale TTM 0.07
FreeCashFlowOnSale 2024 0.06
FreeCashFlowOnSale 2023 0.1
FreeCashFlowOnSale 2022 0.08
NetIncomeMargin TTM -0.13
NetIncomeMargin 2024 -0.05
NetIncomeMargin 2023 -0.04
NetIncomeMargin 2022 0.06
ReturnOnAssets TTM -0.06
ReturnOnAssets 2024 -0.06
ReturnOnAssets 2023 -0.02
ReturnOnAssets 2022 0.03
ReturnOnEquity TTM -0.18
ReturnOnEquity 2024 -0.05
ReturnOnEquity 2023 -0.05
ReturnOnEquity 2022 0.07
Recent news
Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
2026-05-22 · BioSpace
MEDICURE ANNOUNCES AGM RESULTS AND APPOINTMENT OF NEW DIRECTOR
2026-05-21 · Medicure Inc.